Evidence map›Paper›PMID 32936424›Full record

ArticleHuman cell2021

Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression.

Zuo Fei, Yin Lijuan, Zhuang Jing, Yang Xi, Pan Yuefen, Han Shuwen

Abstract read
PubMed Publisher
In one paragraph

Article in Human cell, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. HRAS Induces Ferroptosis through Upregulating HSPB1 in Hepatocellular Carcinoma.Combinatorial chemistry & high throughput screening · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Critical Role of Ferroptosis in Hepatocellular Carcinoma.Frontiers in cell and developmental biology · 2022
    Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Zuo FeiDepartment of Gastroenterology, Huzhou Cent Hospital, Affiliated Cent Hospital HuZhou University, 198 Hongqi Rd, Huzhou, Zhejiang, 313000, People's Republic of China.
Yin LijuanDepartment of Rheumatology, Huzhou Cent Hospital, Affiliated Cent Hospital HuZhou University, 198 Hongqi Rd, Huzhou, Zhejiang, 313000, People's Republic of China.
Zhuang JingGraduate School of Nursing, Huzhou University, No. 1 Bachelor Road, Huzhou, Zhejiang, 313000, China.
Yang XiDepartment of Oncology, Huzhou Cent Hospital, Affiliated Cent Hospital Huzhou University, 198 Hongqi Rd, Huzhou, Zhejiang, 313000, People's Republic of China.
Pan YuefenDepartment of Oncology, Huzhou Cent Hospital, Affiliated Cent Hospital Huzhou University, 198 Hongqi Rd, Huzhou, Zhejiang, 313000, People's Republic of China.
Han ShuwenDepartment of Oncology, Huzhou Cent Hospital, Affiliated Cent Hospital Huzhou University, 198 Hongqi Rd, Huzhou, Zhejiang, 313000, People's Republic of China. shuwenhan985@163.com.ORCID http://orcid.org/0000-0001-6180-9565
Huzhou University · CN

Funding

Zhejiang Medical and Health Technology Projects 2020KY300
6 · The paper itself

Abstract

The aim of this study was to investigate the genes associated with ferroptosis and the progression of hepatocellular carcinoma (HCC). The RNA sequencing data of erastin-induced ferroptosis in HCC cells were downloaded from the Sequence Read Archive database with accession number SRP119173. The microarray dataset GSE89377 of HCC progression was downloaded from the Gene Expression Omnibus database. The ferroptosis-related genes were screened by differential analysis and HCC progression-related genes were screened by cluster analysis using Mfuzz. Then, the genes associated with ferroptosis and HCC progression were screened by Venn analysis, followed by functional enrichment, protein-protein interaction (PPI) analysis, and transcription factor (TF) prediction. Finally, survival analysis was performed using data from the Cancer Genome Atlas database. A total of 33 upregulated and 52 downregulated genes associated with HCC progression and ferroptosis were obtained, and these genes were significantly involved in the negative regulation of ERK1 and ERK2 cascades; the NAD biosynthetic process; alanine, aspartate, and glutamate metabolism; and other pathways. The PPI network contained 52 genes and 78 interactions, of which, cell division cycle 20 (CDC20) and heat shock protein family B (small) member 1 (HSPB1) were hub genes found in higher degrees. Among the 85 genes associated with HCC progression and ferroptosis, two TFs (activating TF 3 (ATF3) and HLF) were predicted, with HSPB1 targeted by ATF3. In addition, 26 genes that were found to be significantly correlated with the overall survival of HCC patients were screened, including CDC20 and thyroid hormone receptor interactor 13. Several genes associated with HCC progression and ferroptosis were screened based on a comprehensive bioinformatics analysis. These genes played roles in HCC progression and ferroptosis via the negative regulation of the ERK1 and ERK2 cascades; the NAD biosynthetic process; and alanine, aspartate, and glutamate metabolism. ATF3 and HSPB1 played important roles in HCC progression and ferroptosis, with HSPB1 possibly regulated by ATF3.

Indexed as

Genetic Association StudiesActivating Transcription Factor 3AlanineCarcinoma, HepatocellularDisease ProgressionFerroptosisGene Expression Regulation, NeoplasticGlutamic AcidHeat-Shock ProteinsHumansLiver NeoplasmsMAP Kinase Signaling SystemMolecular ChaperonesNADSurvival RateActivating Transcription Factor 3AlanineATF3 protein, humanGlutamic AcidHeat-Shock ProteinsHSPB1 protein, humanMolecular ChaperonesNADActivating transcription factor 3FerroptosisHeat shock protein family B member 1Hepatocellular carcinomaOverall survival

Identifiers

PMID32936424
OpenAlexW3087179353

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.